Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors.
Hajime KatoMinae KogaYuka KinoshitaNaoko HidakaYoshitomo HoshinoYuichi TakashiMakoto AraiHiroshi KobayashiMasaki KatsuraYuji NakamotoNaohiro MakiseTetsuo UshikuKazuto HoshiMasaomi NangakuNoriko MakitaSeiji FukumotoNobuaki ItoPublished in: Journal of the Endocrine Society (2022)
We observed the highest localization rate of PMTs in patients with identified PMTs with the combination of FDG-PET and FGF23VS.